
BioTek reMEDys Promotes Autoinflammatory Awareness
BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for year-round enhanced education
BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for year-round enhanced education
Summit Professional Education has partnered with The Knowledge Tree, a leading provider of continuing education for mental health professionals, to expand its offerings beyond rehabilitation
Cedar Gate Technologies, a leading value-based care technology and services company, released a critical analysis of heart health trends across the U.S., revealing that 31%
MemorialCare Saddleback Medical Center announced that it is one of America’s 250 Best Hospitals for 2025, according to new research released by Healthgrades, the No.
Having the optimal blend of products in stock and on the best place on the shelf is critical for retail pharmacies, where competition is high
Rakovina Therapeutics Inc. a biopharmaceutical company at the forefront of AI-driven drug discovery, yesterday commented on the announcement of a $500 billion private-sector investment into
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has extended its 13-year relationship with Tigermed, a leading
RespondHealth, a real-world evidence (RWE) clinical discovery company, is pleased to announce a new integration with to bring AI-powered solutions to the healthcare and life
ThoroughCare, Inc., a leading provider of innovative digital healthcare solutions, has integrated its care management software with PointClickCare, a leading healthcare technology platform enabling meaningful
Anthem Blue Cross and Blue Shield in Ohio announced that Cleveland Clinic, with its Centers of Excellence for cancer care, cardiac services, and other conditions,
Soda Health, a health tech company enhancing the use of benefit dollars to improve health outcomes and reduce inequities, announced a $50M Series B financing.
The Patient-Centered Outcomes Research Institute (PCORI) has approved funding awards totaling more than $156 million for new patient-centered comparative clinical effectiveness research (CER), as well as research